REXCLAV 625
Amoxicillin & Potassium Clavulanate Tablets I.P.
Anti-infective
Schedule H Rx
Genuine RexCure Batch PackagingImage 1 of 1
REXCLAV 457 DS
Amoxicillin & Potassium Clavulanate Oral Suspension IP (DS)
Potentiated broad-spectrum pediatric antibiotic dry suspension formulated in 7:1 ratio to eradicate resistant pathogens.
Strength
400 mg + 57 mg / 5 ml
Commercial Pack
Bottle (30 ml Reconstituted)
Indicative MRP
Rs. 165.00
Drug Class
Schedule H Rx
Active Chemical Composition
Each 5 ml suspension contains:
- Amoxicillin Trihydrate IP eq. to Amoxicillin 400 mg
- Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 57 mg
- Per 5 ml reconstituted
Primary Clinical Indications
1
Acute bacterial otitis media
2
Pediatric acute sinusitis
3
Lower respiratory tract infections
4
Skin and soft tissue infections
Therapeutic Pharmacology & Overview
REXCLAV 457 DS is a double-strength pediatric oral dry syrup combining Amoxicillin with Potassium Clavulanate (7:1 ratio) to restore antibiotic efficacy against beta-lactamase producing bacteria.
Key Formulation Advantages
7:1 high-ratio formulation minimizes clavulanate-induced diarrhea
Effective against beta-lactamase producing amoxicillin-resistant strains
Supplied with sterile water for reconstitution
Palatable pediatric flavor profile ensuring child compliance
Dosage & Administration
Standard Adult / Pediatric Regimen:
Strictly as calculated by body weight and prescribed by pediatrician.
Disclaimer: Dosage must be strictly adjusted by treating physicians based on clinical severity, renal clearance, and body weight.
Packaging & Storage Details
Commercial Presentation:
Amber glass bottle with tamper-evident seal + sterile water ampoule + measuring cup
Storage Monograph:
Store dry powder below 25°C. After reconstitution, refrigerate and use within 7 days.
Market Authorization Holder:
RexCure Pharmaceuticals Pvt. Ltd.
Hyderabad, Telangana
Clinical Inquiry / Sample Request
Healthcare practitioners and hospital pharmacies may request detailed product dossiers, bio-equivalence data, or clinic samples.
Contact Medical DeskDrug Law Compliance
Marketed under Drugs and Cosmetics Act, 1940 and Rules thereunder. Distributed exclusively through licensed pharmaceutical wholesalers and pharmacies.Segment Portfolio
View Area (All) →Related Formulations in Anti-Infectives & Antibacterials
REXCLAV 228.5
Amoxicillin & Potassium Clavulanate Oral Suspension IP